Inventor · disambiguated record
Andrew Baird
Also filed as: BAIRD ANDREW · BAIRD ANDREW J
36 granted patents·7 pending applications·1,069 citations·filing 1985–2017
98Inventor score
Files withAVANIR PHARMACEUTICALS14SELECTIVE GENETICS INC10SALK INST FOR BIOLOGICAL STUDI8CIBLEX CORP2WHITTIER INST DIABETES & ENDOC2
Top patents by PatentIndex Score
43 records- 0195US7084141B2Inhibitors of macrophase migration inhibitory factor and methods for identifying the sameAVANIR PHARMACEUTICALS·Filed 2005·Granted Aug 1, 2006·27 cites·44 claims
- 0294US6054312AReceptor-mediated gene delivery using bacteriophage vectorsSELECTIVE GENETICS INC·Filed 1997·Granted Apr 25, 2000·132 cites·20 claims
- 0394US5155214ABasic fibroblast growth factorSALK INST FOR BIOLOGICAL STUDI·Filed 1990·Granted Oct 13, 1992·138 cites·3 claims
- 0493US5191067AFibroblast growth factor conjugatesSALK INST FOR BIOLOGICAL STUDI·Filed 1989·Granted Mar 2, 1993·80 cites·2 claims
- 0590US7514225B2Method for screening an agent that modulates activity of macrophage migration inhibitory factorAVANIR PHARMACEUTICALS·Filed 2005·Granted Apr 7, 2009·8 cites·11 claims
- 0689US7105519B2Inhibitors of macrophage migration inhibitory factor and methods for identifying the sameAVANIR PHARMACEUTICALS·Filed 2002·Granted Sep 12, 2006·17 cites·107 claims
- 0788US6723512B2Methods using genetic package display for detecting and identifying protein-protein interactions that facilitate internalization and transgene expression and cells or tissues competent for the same and methods for evolving gene delivery vectorsSELECTIVE GENETICS INC·Filed 2001·Granted Apr 20, 2004·27 cites·33 claims
- 0888US6551618B2Compositions and methods for delivery of agents for neuronal regeneration and survivalUNIV BIRMINGHAM·Filed 1998·Granted Apr 22, 2003·77 cites·44 claims
- 0987US7129236B2Inhibitors of macrophage migration inhibitory factor and methods for identifying the sameAVANIR PHARMACEUTICALS·Filed 2006·Granted Oct 31, 2006·5 cites·42 claims
- 1087US6451527B1Methods using genetic package display for selecting internalizing ligands for gene deliverySELECTIVE GENETICS INC·Filed 1999·Granted Sep 17, 2002·56 cites·10 claims
- 1186US4956455ABovine fibroblast growth factorSALK INST FOR BIOLOGICAL STUDI·Filed 1985·Granted Sep 11, 1990·56 cites·7 claims
- 1285US4785079AIsolation of fibroblast growth factorSALK INST FOR BIOLOGICAL STUDI·Filed 1986·Granted Nov 15, 1988·55 cites·13 claims
- 1384US7732146B2Method for screening an agent that modulates activity of macrophage migration inhibitory factorAVANIR PHARMACEUTICALS·Filed 2005·Granted Jun 8, 2010·3 cites·9 claims
- 1484US7192961B2Inhibitors of macrophage migration inhibitory factor and methods for identifying the sameAVANIR PHARMACEUTICALS·Filed 2006·Granted Mar 20, 2007·3 cites·27 claims
- 1582US7432374B2Inhibitors of macrophage migration inhibitory factor and methods for identifying the sameAVANIR PHARMACEUTICALS·Filed 2007·Granted Oct 7, 2008·2 cites·7 claims
- 1682US5132408AFibroblast growth factor antagonistsSALK INST FOR BIOLOGICAL STUDI·Filed 1988·Granted Jul 21, 1992·43 cites·7 claims
- 1781US7435737B2Inhibitors of macrophage migration inhibitory factor and methods for identifying the sameAVANIR PHARMACEUTICALS·Filed 2006·Granted Oct 14, 2008·2 cites·11 claims
- 1881US6448083B1Receptor-mediated gene delivery using bacteriophage vectorsSELECTIVE GENETICS INC·Filed 1999·Granted Sep 10, 2002·39 cites·22 claims
- 1979US6613563B1Viral vectors with modified tropismSELECTIVE GENTICS INC·Filed 1998·Granted Sep 2, 2003·55 cites·7 claims
- 2078US7238809B2Process for the preparation of inhibitors of macrophage migration inhibitory factorAVANIR PHARMACEUTICALS·Filed 2006·Granted Jul 3, 2007·1 cites·24 claims
- 2178US7235565B2Inhibitors of macrophage migration inhibitory factor and methods for identifying the sameAVANIR PHARMACEUTICALS·Filed 2006·Granted Jun 26, 2007·1 cites·52 claims
- 2278US7230106B2Process for the preparation of inhibitors of macrophage migration inhibitory factorAVANIR PHARMACEUTICALS·Filed 2006·Granted Jun 12, 2007·1 cites·19 claims
- 2378US7202248B2Inhibitors of macrophage migration inhibitory factor and methods for identifying the sameAVANIR PHARMACEUTICALS·Filed 2006·Granted Apr 10, 2007·1 cites·62 claims
- 2478US7157469B2Inhibitors of macrophage migration inhibitory factor and methods for identifying the sameAVANIR PHARMACEUTICALS·Filed 2006·Granted Jan 2, 2007·1 cites·42 claims
- 2576US7192955B2Inhibitors of macrophage migration inhibitory factor and methods for identifying the sameAVANIR PHARMACEUTICALS·Filed 2006·Granted Mar 20, 2007·1 cites·52 claims
- 2674US7148202B2Receptor-mediated gene delivery using bacteriophage vectorsSELECTIVE GENETICS INC·Filed 2002·Granted Dec 12, 2006·2 cites·12 claims
- 2773US5958411AMethods of inhibiting ECM accumulation in the CNS by inhibition of TGF-βWHITTIER INST DIABETES & ENDOC·Filed 1995·Granted Sep 28, 1999·28 cites·8 claims
- 2872US6479654B1Forms of the angiogenic factor vascular endothelial cell growth factor: VEGFCOLLATERAL THERAPEUTICS·Filed 1999·Granted Nov 12, 2002·38 cites·6 claims
- 2970US5478804ATreatment of tumorigenic pathophysiological conditions with FGF-cytoxic conjugatesSALK INST FOR BIOLOGICAL STUDI·Filed 1994·Granted Dec 26, 1995·42 cites·19 claims
- 3069US4902782AIsolation of fibroblast growth factorSALK INST FOR BIOLOGICAL STUDI·Filed 1988·Granted Feb 20, 1990·26 cites·10 claims
- 3167US5464774ABovine basic fibroblast growth factorSALK INST FOR BIOLOGICAL STUDI·Filed 1987·Granted Nov 7, 1995·31 cites·3 claims
- 3261US6083706AInhibitors of leaderless protein exportCIBLEX CORP·Filed 1998·Granted Jul 4, 2000·18 cites·6 claims
- 3358US6589730B1Methods for identifying protein-protein interactions by selective transductionSELECTIVE GENETICS INC·Filed 1998·Granted Jul 8, 2003·13 cites·25 claims
- 3455US5670323AProcess for the detection of malignant melanomaWHITTIER INST DIABETES & ENDOC·Filed 1995·Granted Sep 23, 1997·19 cites·24 claims
- 3555US2008152689A1Devices containing dna encoding neurotrophic agents and related compositions and methodsTISSUE REPAIR COMPANY·Filed 2007·Application pending·0 cites
- 3649US2003144200A1Novel forms of the angiogenic factor vascular endothelial cell growth factor: VEGFCOLLATERAL THERAPEUTICS INC·Filed 2002·Application pending·0 cites
- 3748US2004138155A1Devices containing DNA encoding neurotrophic agents and related compositions and methodsSELECTIVE GENETICS INC·Filed 2003·Application pending·0 cites
- 3847US2004029280A1Viral vectors with modified tropismSELECTIVE GENETICS INC·Filed 2003·Application pending·0 cites
- 3946US6472146B1Methods for identification on internalizing ligands and identification of known and putative ligandsSELECTIVE GENETICS INC·Filed 1998·Granted Oct 29, 2002·10 cites·13 claims
- 4045US2003148263A1Methods and compositions using genetic package displaySELECTIVE GENETICS INC·Filed 2002·Application pending·0 cites
- 4145US2003040496A1Methods for halting unwanted cell growth, such as using ligand-directed nucleic acid delivery vehiclesFiled 2001·Application pending·0 cites
- 4241US6306613B1Modulators of leaderless protein export and methods for identifying and using the sameCIBLEX CORP·Filed 1999·Granted Oct 23, 2001·11 cites·8 claims
- 4341US2017266222A1Modulation of chrfam7a for anti-inflammatory therapiesUNIV CALIFORNIA·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Andrew Baird files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →